Literature DB >> 27436126

Modulation of Ionic Channels and Insulin Secretion by Drugs and Hormones in Pancreatic Beta Cells.

Myrian Velasco1, Carlos Manlio Díaz-García1, Carlos Larqué1, Marcia Hiriart2.   

Abstract

Pancreatic beta cells, unique cells that secrete insulin in response to an increase in glucose levels, play a significant role in glucose homeostasis. Glucose-stimulated insulin secretion (GSIS) in pancreatic beta cells has been extensively explored. In this mechanism, glucose enters the cells and subsequently the metabolic cycle. During this process, the ATP/ADP ratio increases, leading to ATP-sensitive potassium (KATP) channel closure, which initiates depolarization that is also dependent on the activity of TRP nonselective ion channels. Depolarization leads to the opening of voltage-gated Na(+) channels (Nav) and subsequently voltage-dependent Ca(2+) channels (Cav). The increase in intracellular Ca(2+) triggers the exocytosis of insulin-containing vesicles. Thus, electrical activity of pancreatic beta cells plays a central role in GSIS. Moreover, many growth factors, incretins, neurotransmitters, and hormones can modulate GSIS, and the channels that participate in GSIS are highly regulated. In this review, we focus on the principal ionic channels (KATP, Nav, and Cav channels) involved in GSIS and how classic and new proteins, hormones, and drugs regulate it. Moreover, we also discuss advances on how metabolic disorders such as metabolic syndrome and diabetes mellitus change channel activity leading to changes in insulin secretion.
Copyright © 2016 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27436126     DOI: 10.1124/mol.116.103861

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  8 in total

1.  Intermittent hypoxia training in prediabetes patients: Beneficial effects on glucose homeostasis, hypoxia tolerance and gene expression.

Authors:  Tetiana V Serebrovska; Alla G Portnychenko; Tetiana I Drevytska; Vladimir I Portnichenko; Lei Xi; Egor Egorov; Anna V Gavalko; Svitlana Naskalova; Valentina Chizhova; Valeriy B Shatylo
Journal:  Exp Biol Med (Maywood)       Date:  2017-07-31

Review 2.  Is Arsenic Exposure a Risk Factor for Metabolic Syndrome? A Review of the Potential Mechanisms.

Authors:  Pablo Pánico; Myrian Velasco; Ana María Salazar; Arturo Picones; Rosa Isela Ortiz-Huidobro; Gabriela Guerrero-Palomo; Manuel Eduardo Salgado-Bernabé; Patricia Ostrosky-Wegman; Marcia Hiriart
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-16       Impact factor: 6.055

3.  Cyanidin Stimulates Insulin Secretion and Pancreatic β-Cell Gene Expression through Activation of l-type Voltage-Dependent Ca2+ Channels.

Authors:  Tanyawan Suantawee; Sara T Elazab; Walter H Hsu; Shaomian Yao; Henrique Cheng; Sirichai Adisakwattana
Journal:  Nutrients       Date:  2017-07-28       Impact factor: 5.717

4.  Early Effects of Metabolic Syndrome on ATP-Sensitive Potassium Channels from Rat Pancreatic Beta Cells.

Authors:  Iskra Cruz-Cruz; Germán Bernate-Obando; Carlos Larqué; Rene Escalona; Rodolfo Pinto-Almazán; Myrian Velasco
Journal:  Metabolites       Date:  2022-04-18

5.  Anthelminthic activity of glibenclamide on secondary cystic echinococcosis in mice.

Authors:  Julia A Loos; María Sandra Churio; Andrea C Cumino
Journal:  PLoS Negl Trop Dis       Date:  2017-11-30

6.  Carbamazepine, a beta-cell protecting drug, reduces type 1 diabetes incidence in NOD mice.

Authors:  Jason T C Lee; Iryna Shanina; Yung Ning Chu; Marc S Horwitz; James D Johnson
Journal:  Sci Rep       Date:  2018-03-15       Impact factor: 4.379

7.  Blocking Ca2+ Channel β3 Subunit Reverses Diabetes.

Authors:  Kayoung Lee; Jaeyoon Kim; Martin Köhler; Jia Yu; Yue Shi; Shao-Nian Yang; Sung Ho Ryu; Per-Olof Berggren
Journal:  Cell Rep       Date:  2018-07-24       Impact factor: 9.423

Review 8.  Molecular Insulin Actions Are Sexually Dimorphic in Lipid Metabolism.

Authors:  Rosa Isela Ortiz-Huidobro; Myrian Velasco; Carlos Larqué; Rene Escalona; Marcia Hiriart
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-18       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.